Menu
Not yet recruiting NCT07424079

Metacognitive Strategy Training Intervention for Transition-Age Youth With Cerebral Palsy

No phase Interventional Cerebral Palsy (CP)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pathways and Resources for Engagement and Participation, Attention Control Condition.
Who it may be relevant to
Registry conditions: Cerebral Palsy (CP). Basic parameters: 13 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Feasibility of Remote Pathways and Resources for Engagement and Participation (PREP) for Transition-Age Youth With Cerebral Palsy and Primary Caregivers

Overview

This exploratory randomized controlled trial will examine the feasibility and preliminary effects of a remote PREP intervention compared to an attention control for transition-age youth with cerebral palsy and their caregivers. Youth-caregiver dyads will complete remote baseline assessments and be randomized to a 12-week intervention or attention control, with weekly virtual sessions. Feasibility outcomes will be primary, with secondary outcomes exploring preliminary efficacy. Post-intervention assessments and optional interviews will be conducted remotely to capture outcomes and participant experiences.

Detailed description

The proposed clinical trial is a single-blind, parallel, exploratory, randomized controlled trial to test the feasibility and effect of remote Pathways and Resources for Engagement and Participation (PREP) compared to attention control for transition-age youth with Cerebral Palsy (CP) and a primary caregiver (i.e., youth-caregiver dyads). Primary outcomes evaluate feasibility of research and intervention protocols, while secondary outcomes allow limited efficacy testing consistent with established feasibility study guidelines. Eligible youth-caregiver dyads will complete a remote baseline assessment session and be randomized to (1) a 12-session remote PREP intervention or (2) a 12-session attention control group. The intervention group will complete one 60-minute session per week for 12 weeks, while the attention control group will meet virtually with the research team once per week for the same duration. Youth-caregiver dyads will complete outcome measures again remotely after the 12-week timeframe. The research team will also invite youths and caregivers to complete a semi-structured interview following PREP or attention control sessions.

Interventions

  • Behavioral Pathways and Resources for Engagement and Participation
    Pathways and Resources for Engagement and Participation (PREP) is a collaborative problem-solving intervention that targets environmental barriers-physical, social, attitudinal, familial, and institutional-while leveraging adolescent and family strengths. Caregivers are integrated as key supports. The five-step process includes: (1) make goals, (2) map out a plan, (3) make it happen, (4) measure outcomes, and (5) move forward. The provider and family will set four activity-based transition goals
  • Behavioral Attention Control Condition
    Youth-caregiver dyads in the attention control group will have dose-equivalent, weekly virtual contact with a research team member who is not involved in remote PREP delivery. The attention control condition will control for interpersonal interaction, maturation, and testing effects. The focus of each session will be (1) social interaction characterized by warmth/empathy and (2) access to The Adult CP Toolkit: Navigating Life with Cerebral Palsy, which is publicly available. The research team me

Primary outcome measures

  • Acceptability of Intervention Measure (AIM) [Time frame: Post-Intervention (Week 13) or Attention Control (Week 13)]
  • Semi-Structured Interview [Time frame: Post-Intervention (Week 13) or Attention Control (Week 13)]
Secondary outcome measures (5)
  • Participation and Environment Measure - Child and Youth [Time frame: Baseline (Week 0); Post-Intervention (Week 13) or Attention Control (Week 13)]
  • Youth, Young Adult Participation and Environment Measure [Time frame: Baseline (Week 0); Post-Intervention (Week 13) or Attention Control (Week 13)]
  • Transition Readiness Scale [Time frame: Baseline (Week 0); Post-Intervention (Week 13) or Attention Control (Week 13)]
  • Canadian Occupational Performance Measure (COPM) [Time frame: Baseline (Week 0); Post-Intervention (Week 13) or Attention Control (Week 13)]
  • Medical Outcomes Study 36-Item Short Form Survey (SF-36) [Time frame: Baseline (Week 0); Post-Intervention (Week 13) or Attention Control (Week 13)]

Eligibility criteria

Inclusion criteria

  • Youth aged 13 -17 with CP and one primary parent, guardian, or caregiver aged 18 or older
  • Youth ability to self-mobilize with or without adaptive equipment measured by the Gross Motor Function Scale-Expanded \& Revised (GMFCS-E\&R) Levels I - III
  • Effective youth communication measured by Communication Function Classification System (CFCS) Levels I - III
  • Ability to read, speak, and write English
  • Willingness to participate in all aspects of the proposed study.

Exclusion criteria

  • Youth with profound intellectual disability
  • Youth with severe mental health conditions
  • Youth who engage in community-based transition services redundant with remote PREP

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • University of Missouri - Columbia — Columbia

Identifiers

NCT: NCT07424079 · 2132811

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗